Morning sudden cardiac death

Area of Science:

• Cardiology
• Chronobiology
• Pharmacology

Background:

• Circadian variations in cardiac function, platelet aggregability, sympathetic nervous system activity, and blood pressure are known, peaking in the morning.
• These morning physiological changes are associated with a higher incidence of sudden cardiac death.
• Current primary prevention strategies for sudden death in high-risk patients include defibrillators and various medications, with aspirin being a recent addition.

Purpose of the Study:

• To explore the potential of early and continuous low-dose aspirin administration for preventing myocardial infarction and morning sudden cardiac death.
• To evaluate aspirin's role in mitigating morning-specific cardiovascular risks.

Main Methods:

• Review of existing literature on circadian rhythms and cardiovascular events.
• Analysis of aspirin's mechanism of action, specifically its antiplatelet and antithrombin effects.
• Hypothetical extrapolation of aspirin's preventive efficacy in both high-risk and general populations.

Main Results:

• Morning hours exhibit heightened cardiovascular risks due to physiological circadian variations.
• Low-dose aspirin inhibits platelet aggregation and thrombin formation.
• Continuous aspirin use, particularly during morning hours, is predicted to reduce myocardial infarction and sudden cardiac death incidence.

Conclusions:

• The morning peak in cardiovascular events is linked to circadian physiological changes.
• Early and continuous low-dose aspirin therapy shows promise for preventing myocardial infarction and morning sudden cardiac death.
• Aspirin's antiplatelet effects may counteract the prothrombotic state observed in morning hours.